nodes	percent_of_prediction	percent_of_DWPC	metapath
Ranitidine—ABCB1—peripheral nervous system neoplasm	0.359	1	CbGaD
Ranitidine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.055	0.125	CbGbCtD
Ranitidine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.044	0.1	CbGbCtD
Ranitidine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0385	0.0875	CbGbCtD
Ranitidine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0385	0.0875	CbGbCtD
Ranitidine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0352	0.08	CbGbCtD
Ranitidine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0267	0.0607	CbGbCtD
Ranitidine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0252	0.0574	CbGbCtD
Ranitidine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0231	0.0526	CbGbCtD
Ranitidine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0231	0.0524	CbGbCtD
Ranitidine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0214	0.0488	CbGbCtD
Ranitidine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0172	0.0392	CbGbCtD
Ranitidine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0164	0.0374	CbGbCtD
Ranitidine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0153	0.0348	CbGbCtD
Ranitidine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0151	0.0342	CbGbCtD
Ranitidine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0103	0.0234	CbGbCtD
Ranitidine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00984	0.0224	CbGbCtD
Ranitidine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00968	0.022	CbGbCtD
Ranitidine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00902	0.0205	CbGbCtD
Ranitidine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00615	0.014	CbGbCtD
Ranitidine—Nizatidine—BCHE—peripheral nervous system neoplasm	0.00601	0.719	CrCbGaD
Ranitidine—Nizatidine—ABCB1—peripheral nervous system neoplasm	0.00235	0.282	CrCbGaD
Ranitidine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.000247	0.00128	CcSEcCtD
Ranitidine—Anaemia—Cisplatin—peripheral nervous system neoplasm	0.000246	0.00128	CcSEcCtD
Ranitidine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.000246	0.00128	CcSEcCtD
Ranitidine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000245	0.00127	CcSEcCtD
Ranitidine—Thrombocytopenia—Vincristine—peripheral nervous system neoplasm	0.000241	0.00125	CcSEcCtD
Ranitidine—Malaise—Cisplatin—peripheral nervous system neoplasm	0.00024	0.00125	CcSEcCtD
Ranitidine—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00024	0.00125	CcSEcCtD
Ranitidine—Photosensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00024	0.00124	CcSEcCtD
Ranitidine—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.000239	0.00124	CcSEcCtD
Ranitidine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00124	CcSEcCtD
Ranitidine—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000238	0.00124	CcSEcCtD
Ranitidine—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000238	0.00124	CcSEcCtD
Ranitidine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000238	0.00123	CcSEcCtD
Ranitidine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000236	0.00122	CcSEcCtD
Ranitidine—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000235	0.00122	CcSEcCtD
Ranitidine—Hepatic failure—Doxorubicin—peripheral nervous system neoplasm	0.000234	0.00121	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.000233	0.00121	CcSEcCtD
Ranitidine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000232	0.00121	CcSEcCtD
Ranitidine—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000231	0.0012	CcSEcCtD
Ranitidine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000231	0.0012	CcSEcCtD
Ranitidine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000231	0.0012	CcSEcCtD
Ranitidine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00023	0.00119	CcSEcCtD
Ranitidine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000228	0.00118	CcSEcCtD
Ranitidine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000228	0.00118	CcSEcCtD
Ranitidine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000227	0.00118	CcSEcCtD
Ranitidine—Myalgia—Cisplatin—peripheral nervous system neoplasm	0.000227	0.00118	CcSEcCtD
Ranitidine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000227	0.00118	CcSEcCtD
Ranitidine—Ill-defined disorder—Etoposide—peripheral nervous system neoplasm	0.000227	0.00117	CcSEcCtD
Ranitidine—Anaemia—Etoposide—peripheral nervous system neoplasm	0.000226	0.00117	CcSEcCtD
Ranitidine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000225	0.00116	CcSEcCtD
Ranitidine—Discomfort—Cisplatin—peripheral nervous system neoplasm	0.000224	0.00116	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000224	0.00116	CcSEcCtD
Ranitidine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000223	0.00116	CcSEcCtD
Ranitidine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000223	0.00116	CcSEcCtD
Ranitidine—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000223	0.00115	CcSEcCtD
Ranitidine—Malaise—Etoposide—peripheral nervous system neoplasm	0.00022	0.00114	CcSEcCtD
Ranitidine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000219	0.00114	CcSEcCtD
Ranitidine—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.000219	0.00113	CcSEcCtD
Ranitidine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00113	CcSEcCtD
Ranitidine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00113	CcSEcCtD
Ranitidine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000218	0.00113	CcSEcCtD
Ranitidine—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000218	0.00113	CcSEcCtD
Ranitidine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000218	0.00113	CcSEcCtD
Ranitidine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00112	CcSEcCtD
Ranitidine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000216	0.00112	CcSEcCtD
Ranitidine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000214	0.00111	CcSEcCtD
Ranitidine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000214	0.00111	CcSEcCtD
Ranitidine—Rash—Topotecan—peripheral nervous system neoplasm	0.000214	0.00111	CcSEcCtD
Ranitidine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000214	0.00111	CcSEcCtD
Ranitidine—Thrombocytopenia—Cisplatin—peripheral nervous system neoplasm	0.000213	0.0011	CcSEcCtD
Ranitidine—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000213	0.0011	CcSEcCtD
Ranitidine—Headache—Topotecan—peripheral nervous system neoplasm	0.000213	0.0011	CcSEcCtD
Ranitidine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000212	0.0011	CcSEcCtD
Ranitidine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000212	0.0011	CcSEcCtD
Ranitidine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.000212	0.0011	CcSEcCtD
Ranitidine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000212	0.0011	CcSEcCtD
Ranitidine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000212	0.0011	CcSEcCtD
Ranitidine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000211	0.0011	CcSEcCtD
Ranitidine—Headache—Tretinoin—peripheral nervous system neoplasm	0.000211	0.00109	CcSEcCtD
Ranitidine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000211	0.00109	CcSEcCtD
Ranitidine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00109	CcSEcCtD
Ranitidine—Pain—Vincristine—peripheral nervous system neoplasm	0.00021	0.00109	CcSEcCtD
Ranitidine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00021	0.00109	CcSEcCtD
Ranitidine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00021	0.00109	CcSEcCtD
Ranitidine—Rash—Melphalan—peripheral nervous system neoplasm	0.00021	0.00109	CcSEcCtD
Ranitidine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00021	0.00109	CcSEcCtD
Ranitidine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000208	0.00108	CcSEcCtD
Ranitidine—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.000208	0.00108	CcSEcCtD
Ranitidine—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000205	0.00107	CcSEcCtD
Ranitidine—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000205	0.00107	CcSEcCtD
Ranitidine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000203	0.00105	CcSEcCtD
Ranitidine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000203	0.00105	CcSEcCtD
Ranitidine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000203	0.00105	CcSEcCtD
Ranitidine—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.00105	CcSEcCtD
Ranitidine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000202	0.00105	CcSEcCtD
Ranitidine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000202	0.00105	CcSEcCtD
Ranitidine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000201	0.00104	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Epirubicin—peripheral nervous system neoplasm	0.000201	0.00104	CcSEcCtD
Ranitidine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.0002	0.00104	CcSEcCtD
Ranitidine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.0002	0.00104	CcSEcCtD
Ranitidine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00104	CcSEcCtD
Ranitidine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000199	0.00103	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000198	0.00103	CcSEcCtD
Ranitidine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000198	0.00102	CcSEcCtD
Ranitidine—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000197	0.00102	CcSEcCtD
Ranitidine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000197	0.00102	CcSEcCtD
Ranitidine—Thrombocytopenia—Etoposide—peripheral nervous system neoplasm	0.000195	0.00101	CcSEcCtD
Ranitidine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000195	0.00101	CcSEcCtD
Ranitidine—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00101	CcSEcCtD
Ranitidine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000195	0.00101	CcSEcCtD
Ranitidine—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000195	0.00101	CcSEcCtD
Ranitidine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000194	0.00101	CcSEcCtD
Ranitidine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000193	0.000999	CcSEcCtD
Ranitidine—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000193	0.000999	CcSEcCtD
Ranitidine—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.000192	0.000996	CcSEcCtD
Ranitidine—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000191	0.000992	CcSEcCtD
Ranitidine—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.00019	0.000986	CcSEcCtD
Ranitidine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000188	0.000977	CcSEcCtD
Ranitidine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000188	0.000976	CcSEcCtD
Ranitidine—Pancytopenia—Epirubicin—peripheral nervous system neoplasm	0.000187	0.000968	CcSEcCtD
Ranitidine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000186	0.000966	CcSEcCtD
Ranitidine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000186	0.000965	CcSEcCtD
Ranitidine—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	0.000186	0.000962	CcSEcCtD
Ranitidine—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000184	0.000953	CcSEcCtD
Ranitidine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000182	0.000943	CcSEcCtD
Ranitidine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000181	0.00094	CcSEcCtD
Ranitidine—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000181	0.000937	CcSEcCtD
Ranitidine—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.00018	0.000933	CcSEcCtD
Ranitidine—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000179	0.00093	CcSEcCtD
Ranitidine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000179	0.00093	CcSEcCtD
Ranitidine—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.000178	0.000924	CcSEcCtD
Ranitidine—Weight decreased—Epirubicin—peripheral nervous system neoplasm	0.000178	0.000922	CcSEcCtD
Ranitidine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000178	0.000921	CcSEcCtD
Ranitidine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000177	0.000919	CcSEcCtD
Ranitidine—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.000918	CcSEcCtD
Ranitidine—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000176	0.000914	CcSEcCtD
Ranitidine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000175	0.000908	CcSEcCtD
Ranitidine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000175	0.000906	CcSEcCtD
Ranitidine—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000174	0.0009	CcSEcCtD
Ranitidine—Pancytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000173	0.000895	CcSEcCtD
Ranitidine—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000172	0.000892	CcSEcCtD
Ranitidine—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000171	0.000885	CcSEcCtD
Ranitidine—Pain—Etoposide—peripheral nervous system neoplasm	0.00017	0.000884	CcSEcCtD
Ranitidine—Constipation—Etoposide—peripheral nervous system neoplasm	0.00017	0.000884	CcSEcCtD
Ranitidine—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.00017	0.000881	CcSEcCtD
Ranitidine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000169	0.000876	CcSEcCtD
Ranitidine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000168	0.000873	CcSEcCtD
Ranitidine—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000168	0.000871	CcSEcCtD
Ranitidine—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000166	0.00086	CcSEcCtD
Ranitidine—Weight decreased—Doxorubicin—peripheral nervous system neoplasm	0.000164	0.000853	CcSEcCtD
Ranitidine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000164	0.000852	CcSEcCtD
Ranitidine—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000164	0.000848	CcSEcCtD
Ranitidine—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.000164	0.000848	CcSEcCtD
Ranitidine—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.000163	0.000845	CcSEcCtD
Ranitidine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000163	0.000844	CcSEcCtD
Ranitidine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000162	0.000842	CcSEcCtD
Ranitidine—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000835	CcSEcCtD
Ranitidine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000161	0.000834	CcSEcCtD
Ranitidine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00016	0.000831	CcSEcCtD
Ranitidine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.00016	0.00083	CcSEcCtD
Ranitidine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00016	0.000829	CcSEcCtD
Ranitidine—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000158	0.000821	CcSEcCtD
Ranitidine—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000158	0.000819	CcSEcCtD
Ranitidine—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000158	0.000817	CcSEcCtD
Ranitidine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000158	0.000817	CcSEcCtD
Ranitidine—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000815	CcSEcCtD
Ranitidine—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000156	0.000811	CcSEcCtD
Ranitidine—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000155	0.000806	CcSEcCtD
Ranitidine—Rash—Vincristine—peripheral nervous system neoplasm	0.000155	0.000804	CcSEcCtD
Ranitidine—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000155	0.000804	CcSEcCtD
Ranitidine—Headache—Vincristine—peripheral nervous system neoplasm	0.000154	0.000799	CcSEcCtD
Ranitidine—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000786	CcSEcCtD
Ranitidine—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000151	0.000784	CcSEcCtD
Ranitidine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000149	0.000772	CcSEcCtD
Ranitidine—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000771	CcSEcCtD
Ranitidine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000148	0.000768	CcSEcCtD
Ranitidine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000147	0.000761	CcSEcCtD
Ranitidine—Nausea—Vincristine—peripheral nervous system neoplasm	0.000146	0.000758	CcSEcCtD
Ranitidine—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	0.000146	0.000755	CcSEcCtD
Ranitidine—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000141	0.000731	CcSEcCtD
Ranitidine—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	0.000141	0.000728	CcSEcCtD
Ranitidine—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000721	CcSEcCtD
Ranitidine—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000138	0.000717	CcSEcCtD
Ranitidine—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000713	CcSEcCtD
Ranitidine—Rash—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000711	CcSEcCtD
Ranitidine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000137	0.000711	CcSEcCtD
Ranitidine—Erythema—Epirubicin—peripheral nervous system neoplasm	0.000137	0.00071	CcSEcCtD
Ranitidine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000136	0.000707	CcSEcCtD
Ranitidine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000132	0.000683	CcSEcCtD
Ranitidine—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000674	CcSEcCtD
Ranitidine—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000129	0.00067	CcSEcCtD
Ranitidine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000669	CcSEcCtD
Ranitidine—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000667	CcSEcCtD
Ranitidine—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000659	CcSEcCtD
Ranitidine—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000127	0.000657	CcSEcCtD
Ranitidine—Erythema—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000657	CcSEcCtD
Ranitidine—Anaemia—Epirubicin—peripheral nervous system neoplasm	0.000127	0.000656	CcSEcCtD
Ranitidine—Agitation—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000652	CcSEcCtD
Ranitidine—Rash—Etoposide—peripheral nervous system neoplasm	0.000126	0.000652	CcSEcCtD
Ranitidine—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000126	0.000651	CcSEcCtD
Ranitidine—Headache—Etoposide—peripheral nervous system neoplasm	0.000125	0.000647	CcSEcCtD
Ranitidine—Malaise—Epirubicin—peripheral nervous system neoplasm	0.000123	0.00064	CcSEcCtD
Ranitidine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000638	CcSEcCtD
Ranitidine—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000635	CcSEcCtD
Ranitidine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000619	CcSEcCtD
Ranitidine—Nausea—Etoposide—peripheral nervous system neoplasm	0.000118	0.000614	CcSEcCtD
Ranitidine—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000609	CcSEcCtD
Ranitidine—Anaemia—Doxorubicin—peripheral nervous system neoplasm	0.000117	0.000607	CcSEcCtD
Ranitidine—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000604	CcSEcCtD
Ranitidine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000604	CcSEcCtD
Ranitidine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000604	CcSEcCtD
Ranitidine—Agitation—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000604	CcSEcCtD
Ranitidine—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000597	CcSEcCtD
Ranitidine—Malaise—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000592	CcSEcCtD
Ranitidine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.00059	CcSEcCtD
Ranitidine—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000588	CcSEcCtD
Ranitidine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000584	CcSEcCtD
Ranitidine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000579	CcSEcCtD
Ranitidine—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000567	CcSEcCtD
Ranitidine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000109	0.000565	CcSEcCtD
Ranitidine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000108	0.00056	CcSEcCtD
Ranitidine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000559	CcSEcCtD
Ranitidine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000559	CcSEcCtD
Ranitidine—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000559	CcSEcCtD
Ranitidine—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000552	CcSEcCtD
Ranitidine—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000541	CcSEcCtD
Ranitidine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000541	CcSEcCtD
Ranitidine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000536	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000102	0.000528	CcSEcCtD
Ranitidine—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000525	CcSEcCtD
Ranitidine—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000524	CcSEcCtD
Ranitidine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000101	0.000523	CcSEcCtD
Ranitidine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.0001	0.000518	CcSEcCtD
Ranitidine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.96e-05	0.000517	CcSEcCtD
Ranitidine—Somnolence—Epirubicin—peripheral nervous system neoplasm	9.93e-05	0.000515	CcSEcCtD
Ranitidine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.66e-05	0.000501	CcSEcCtD
Ranitidine—Pain—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000495	CcSEcCtD
Ranitidine—Constipation—Epirubicin—peripheral nervous system neoplasm	9.56e-05	0.000495	CcSEcCtD
Ranitidine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	9.42e-05	0.000488	CcSEcCtD
Ranitidine—Insomnia—Doxorubicin—peripheral nervous system neoplasm	9.35e-05	0.000485	CcSEcCtD
Ranitidine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	9.22e-05	0.000478	CcSEcCtD
Ranitidine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000477	CcSEcCtD
Ranitidine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	9.19e-05	0.000477	CcSEcCtD
Ranitidine—Urticaria—Epirubicin—peripheral nervous system neoplasm	8.88e-05	0.00046	CcSEcCtD
Ranitidine—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000458	CcSEcCtD
Ranitidine—Pain—Doxorubicin—peripheral nervous system neoplasm	8.84e-05	0.000458	CcSEcCtD
Ranitidine—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.83e-05	0.000458	CcSEcCtD
Ranitidine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.83e-05	0.000458	CcSEcCtD
Ranitidine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000442	CcSEcCtD
Ranitidine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	8.23e-05	0.000427	CcSEcCtD
Ranitidine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	8.21e-05	0.000426	CcSEcCtD
Ranitidine—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	8.17e-05	0.000424	CcSEcCtD
Ranitidine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	8.17e-05	0.000424	CcSEcCtD
Ranitidine—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.91e-05	0.00041	CcSEcCtD
Ranitidine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000396	CcSEcCtD
Ranitidine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000395	CcSEcCtD
Ranitidine—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000383	CcSEcCtD
Ranitidine—Pruritus—Doxorubicin—peripheral nervous system neoplasm	7.32e-05	0.000379	CcSEcCtD
Ranitidine—Vomiting—Epirubicin—peripheral nervous system neoplasm	7.1e-05	0.000368	CcSEcCtD
Ranitidine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	7.07e-05	0.000367	CcSEcCtD
Ranitidine—Rash—Epirubicin—peripheral nervous system neoplasm	7.05e-05	0.000365	CcSEcCtD
Ranitidine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.000365	CcSEcCtD
Ranitidine—Headache—Epirubicin—peripheral nervous system neoplasm	7e-05	0.000363	CcSEcCtD
Ranitidine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000354	CcSEcCtD
Ranitidine—Nausea—Epirubicin—peripheral nervous system neoplasm	6.64e-05	0.000344	CcSEcCtD
Ranitidine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.57e-05	0.000341	CcSEcCtD
Ranitidine—Rash—Doxorubicin—peripheral nervous system neoplasm	6.52e-05	0.000338	CcSEcCtD
Ranitidine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.51e-05	0.000338	CcSEcCtD
Ranitidine—Headache—Doxorubicin—peripheral nervous system neoplasm	6.48e-05	0.000336	CcSEcCtD
Ranitidine—Nausea—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000318	CcSEcCtD
